Concord Medical Services Stock Working Capital

CCM Stock

USD 5.00 0.56 12.61%

Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.

	Last Reported	Projected for Next Year
Net Working Capital	-1.3 B	-1.3 B
Change In Working Capital	-55 M	-57.8 M

As of the 26th of November 2024, Net Working Capital is likely to grow to about (1.3 B). In addition to that, Change In Working Capital is likely to drop to about (57.8 M).

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Concord Medical Services Company Working Capital Analysis

Concord Medical's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Concord Medical Working Capital

(1.33 B)

Most of Concord Medical's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Concord Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Working Capital. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Long Term Debt	Good Will	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Short Term Debt	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.57	0.78	0.64	0.83	0.71	0.72	0.75	0.73	0.79	-0.73	0.54	-0.18	-0.13	0.21	-0.33	-0.63	-0.77	0.3	0.33	-0.32	0.74	0.67	0.1	-0.77	-0.35	-0.17
Total Stockholder Equity	-0.57		-0.92	-0.74	-0.82	-0.49	-0.04	-0.94	-0.73	-0.86	0.95	-0.47	0.8	0.6	-0.14	0.78	0.65	0.91	-0.27	-0.39	0.16	-0.94	-0.68	-0.03	0.91	0.69	0.57
Long Term Debt	0.78	-0.92		0.76	0.9	0.62	0.32	0.98	0.83	0.94	-0.96	0.52	-0.65	-0.52	0.13	-0.66	-0.72	-0.94	0.41	0.33	-0.32	0.98	0.74	0.0	-0.9	-0.6	-0.46
Good Will	0.64	-0.74	0.76		0.72	0.33	0.32	0.82	0.65	0.81	-0.87	0.84	-0.7	-0.49	0.24	-0.4	-0.28	-0.76	0.11	0.28	0.16	0.79	0.31	-0.02	-0.81	-0.75	-0.63
Total Liab	0.83	-0.82	0.9	0.72		0.61	0.53	0.93	0.65	0.96	-0.9	0.58	-0.44	-0.22	0.5	-0.6	-0.77	-0.88	0.39	0.42	-0.29	0.92	0.81	0.03	-0.85	-0.68	-0.6
Intangible Assets	0.71	-0.49	0.62	0.33	0.61		0.35	0.55	0.56	0.49	-0.51	0.16	-0.15	-0.11	-0.14	-0.46	-0.77	-0.6	0.26	0.38	-0.46	0.54	0.72	0.2	-0.63	0.03	0.06
Common Stock	0.72	-0.04	0.32	0.32	0.53	0.35		0.35	0.19	0.45	-0.29	0.25	0.27	0.27	0.44	0.2	-0.38	-0.35	0.19	0.11	-0.27	0.33	0.42	0.02	-0.31	-0.22	-0.17
Property Plant Equipment	0.75	-0.94	0.98	0.82	0.93	0.55	0.35		0.74	0.96	-0.98	0.55	-0.69	-0.53	0.24	-0.66	-0.7	-0.94	0.37	0.32	-0.24	1.0	0.73	0.02	-0.94	-0.73	-0.61
Current Deferred Revenue	0.73	-0.73	0.83	0.65	0.65	0.56	0.19	0.74		0.7	-0.78	0.52	-0.47	-0.39	-0.14	-0.52	-0.48	-0.76	0.17	0.45	-0.14	0.75	0.49	0.19	-0.72	-0.25	-0.11
Net Debt	0.79	-0.86	0.94	0.81	0.96	0.49	0.45	0.96	0.7		-0.94	0.66	-0.58	-0.39	0.42	-0.62	-0.67	-0.9	0.4	0.34	-0.21	0.96	0.71	-0.11	-0.85	-0.76	-0.62
Retained Earnings	-0.73	0.95	-0.96	-0.87	-0.9	-0.51	-0.29	-0.98	-0.78	-0.94		-0.61	0.74	0.54	-0.23	0.66	0.63	0.95	-0.29	-0.39	0.14	-0.98	-0.66	-0.02	0.94	0.75	0.61
Accounts Payable	0.54	-0.47	0.52	0.84	0.58	0.16	0.25	0.55	0.52	0.66	-0.61		-0.4	-0.18	0.41	-0.27	-0.05	-0.49	0.04	0.24	0.31	0.53	0.08	-0.11	-0.52	-0.6	-0.48
Net Receivables	-0.18	0.8	-0.65	-0.7	-0.44	-0.15	0.27	-0.69	-0.47	-0.58	0.74	-0.4		0.8	0.06	0.66	0.25	0.61	-0.24	-0.1	-0.13	-0.68	-0.28	0.12	0.67	0.68	0.53
Total Current Assets	-0.13	0.6	-0.52	-0.49	-0.22	-0.11	0.27	-0.53	-0.39	-0.39	0.54	-0.18	0.8		0.36	0.56	0.24	0.43	-0.12	-0.11	-0.19	-0.51	-0.2	0.26	0.51	0.41	0.21
Short Term Debt	0.21	-0.14	0.13	0.24	0.5	-0.14	0.44	0.24	-0.14	0.42	-0.23	0.41	0.06	0.36		-0.09	-0.19	-0.14	0.18	0.16	0.11	0.23	0.28	-0.1	-0.13	-0.6	-0.64
Short Term Investments	-0.33	0.78	-0.66	-0.4	-0.6	-0.46	0.2	-0.66	-0.52	-0.62	0.66	-0.27	0.66	0.56	-0.09		0.66	0.57	-0.33	-0.5	0.03	-0.66	-0.65	0.05	0.61	0.42	0.34
Treasury Stock	-0.63	0.65	-0.72	-0.28	-0.77	-0.77	-0.38	-0.7	-0.48	-0.67	0.63	-0.05	0.25	0.24	-0.19	0.66		0.64	-0.43	-0.48	0.39	-0.7	-0.98	-0.08	0.66	0.27	0.23
Net Tangible Assets	-0.77	0.91	-0.94	-0.76	-0.88	-0.6	-0.35	-0.94	-0.76	-0.9	0.95	-0.49	0.61	0.43	-0.14	0.57	0.64		-0.2	-0.3	0.38	-0.94	-0.67	-0.05	0.95	0.62	0.48
Deferred Long Term Liab	0.3	-0.27	0.41	0.11	0.39	0.26	0.19	0.37	0.17	0.4	-0.29	0.04	-0.24	-0.12	0.18	-0.33	-0.43	-0.2		-0.17	-0.39	0.4	0.53	-0.19	-0.19	-0.24	-0.11
Long Term Investments	0.33	-0.39	0.33	0.28	0.42	0.38	0.11	0.32	0.45	0.34	-0.39	0.24	-0.1	-0.11	0.16	-0.5	-0.48	-0.3	-0.17		0.3	0.32	0.43	0.01	-0.33	-0.14	-0.13
Short Long Term Debt	-0.32	0.16	-0.32	0.16	-0.29	-0.46	-0.27	-0.24	-0.14	-0.21	0.14	0.31	-0.13	-0.19	0.11	0.03	0.39	0.38	-0.39	0.3		-0.27	-0.41	-0.18	0.22	-0.15	-0.09
Long Term Debt Total	0.74	-0.94	0.98	0.79	0.92	0.54	0.33	1.0	0.75	0.96	-0.98	0.53	-0.68	-0.51	0.23	-0.66	-0.7	-0.94	0.4	0.32	-0.27		0.74	0.02	-0.92	-0.72	-0.6
Capital Surpluse	0.67	-0.68	0.74	0.31	0.81	0.72	0.42	0.73	0.49	0.71	-0.66	0.08	-0.28	-0.2	0.28	-0.65	-0.98	-0.67	0.53	0.43	-0.41	0.74		0.05	-0.67	-0.37	-0.28
Cash And Equivalents	0.1	-0.03	0.0	-0.02	0.03	0.2	0.02	0.02	0.19	-0.11	-0.02	-0.11	0.12	0.26	-0.1	0.05	-0.08	-0.05	-0.19	0.01	-0.18	0.02	0.05		-0.19	0.26	-0.08
Net Invested Capital	-0.77	0.91	-0.9	-0.81	-0.85	-0.63	-0.31	-0.94	-0.72	-0.85	0.94	-0.52	0.67	0.51	-0.13	0.61	0.66	0.95	-0.19	-0.33	0.22	-0.92	-0.67	-0.19		0.63	0.52
Net Working Capital	-0.35	0.69	-0.6	-0.75	-0.68	0.03	-0.22	-0.73	-0.25	-0.76	0.75	-0.6	0.68	0.41	-0.6	0.42	0.27	0.62	-0.24	-0.14	-0.15	-0.72	-0.37	0.26	0.63		0.87
Capital Stock	-0.17	0.57	-0.46	-0.63	-0.6	0.06	-0.17	-0.61	-0.11	-0.62	0.61	-0.48	0.53	0.21	-0.64	0.34	0.23	0.48	-0.11	-0.13	-0.09	-0.6	-0.28	-0.08	0.52	0.87

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict Concord Medical

Working Capital Over Time

Concord Capital Surpluse

Capital Surpluse

1.76 Billion

At this time, Concord Medical's Capital Surpluse is very stable compared to the past year.

In accordance with the company's disclosures, Concord Medical Services has a Working Capital of (1.33 Billion). This is 413.45% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The working capital for all United States stocks is 190.26% higher than that of the company.

Concord Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.

Concord Medical is currently under evaluation in working capital category among its peers.

Concord Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	806.3M	781.0M	555.0M	494.1M	356.5M	338.7M
Enterprise Value	2.6B	2.8B	3.1B	3.6B	3.6B	6.9B

Concord Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Concord Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Concord Medical's managers, analysts, and investors.

Environmental

Governance

Social

Concord Fundamentals

	Return On Equity	-0.32
	Return On Asset	-0.044
	Profit Margin	(0.80) %
	Operating Margin	(0.90) %
	Current Valuation	466.69 M
	Shares Outstanding	2.82 M
	Shares Owned By Insiders	17.99 %
	Shares Owned By Institutions	0.10 %
	Number Of Shares Shorted	11.4 K
	Price To Earning	(3.90) X
	Price To Book	3.00 X
	Price To Sales	0.04 X
	Revenue	537.4 M
	Gross Profit	(152.41 M)
	EBITDA	(313.75 M)
	Net Income	(531.02 M)
	Cash And Equivalents	157.39 M
	Cash Per Share	1.72 X
	Total Debt	3.3 B
	Debt To Equity	1.25 %
	Current Ratio	0.71 X
	Book Value Per Share	(489.59) X
	Cash Flow From Operations	(276.47 M)
	Short Ratio	2.14 X
	Earnings Per Share	(11.98) X
	Target Price	1.2
	Number Of Employees	727
	Beta	-0.27
	Market Capitalization	19.28 M
	Total Asset	6.05 B
	Retained Earnings	(4.06 B)
	Working Capital	(1.33 B)
	Current Asset	1.51 B
	Current Liabilities	1.51 B
	Net Asset	6.05 B

About Concord Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:

How To Invest In Concord

Details

Is Concord Stock a good investment?

Details

What is Concord Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(11.98)

Revenue Per Share

107.978

Quarterly Revenue Growth

(0.23)

Return On Assets

(0.04)

Return On Equity

(0.32)

The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Concord Medical Services Stock Working Capital

Concord Medical Services Company Working Capital Analysis

Working Capital

Current Assets

-

Current Liabilities

Current Concord Medical Working Capital

Concord Working Capital Driver Correlations

Concord Capital Surpluse

Capital Surpluse

1.76 Billion

Concord Working Capital Peer Comparison

Concord Medical Current Valuation Drivers

Concord Medical ESG Sustainability

Concord Fundamentals

About Concord Medical Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY